Skip to main content
. 2016 Aug 11;16:281. doi: 10.1186/s12906-016-1267-x

Fig. 2.

Fig. 2

mRNA levels of JNK/SAPK and p38MAPK pathway members. Cells treated with 50 μM QU and 50 μM QU + 5 μg/ml CIS. Two-fold or more differences compared to control cells were evaluated by RT2-PCR array Group 1: DMSO Control versus Quercetin; Group 2: DMSO control versus Quercetin + Cisplatin